Mar 15, 2019 | CanaudLab EN
On February 27, 2019, the Canaud Lab received $20,000 from the CLOVES Syndrome Community for the creation of animal models to test PIK3CA inhibitors and to study PIK3CA related overgrowth physiopathology. We are thankful and ready to take action. Learn more about the...
Nov 9, 2018 | CanaudLab EN
On October 16 2018, the Canaud Lab was awarded with the Jean-Pierre Lecocq Prize from the French Academy of Sciences. Each year since 1992, this prize allocates 30 000 € for outstanding research projects in Applied and Fundamental sciences. Learn more about the French...
Nov 9, 2018 | CanaudLab EN
In October 2018, the Canaud Lab received a donation from the CLOVES Syndrome Community. This donation will be used for the creation of animal models to test PIK3CA inhibitors. Learn more about the CLOVES Syndrome Community
Jul 3, 2018 | CanaudLab EN
In 2018, Guillaume Canaud received a grant from the Simone and Cino Del Duca Foundation. Three annual grants are intended for young French teams leading research projects in annually defined fields (chemistry, cellular and molecular biology, genomics, integrative...
Jul 3, 2018 | CanaudLab EN
On March 5, 2018, Guillaume Canaud received the Institut Necker Prize during the annual ceremony of the Tourre Foundation, held at the Paris Descartes University, in the presence of a large audience. Since 2011, the Tourre Foundation has allocated a total of € 395,000...
Jun 15, 2018 | CanaudLab EN
Congratulation to Quitterie for her work on PIK3CA inhibition in patients with PIKC3CA Related Overgrowth Syndrome published in Nature! The team recently demonstrated the efficacy of a novel medication, a specific inhibitor called BYL719, in a cohort of 19 patients...
